Kioxia: Still A 'Buy' Considering ADS Listing And LTAs

Kioxia Holdings remains rated Buy on expectations for a U.S. ADS listing targeted for FY27 and expanding long-term agreements covering 50% of 2028 shipments. The listing is expected to narrow Kioxia’s P/E discount versus Sandisk, while the LTAs improve revenue visibility and reduce cyclicality. The update is constructive for valuation and fundamental durability, though it is still a medium-term catalyst rather than an immediate earnings event.

Analysis

The market is likely underappreciating how a credible U.S. listing changes the investor base rather than just the multiple. Once Kioxia has an ADS, passive index inclusion, U.S. liquidity, and a cleaner comparable set versus SNDK can compress the governance/liquidity discount that typically keeps Japanese memory names cheap despite improving fundamentals. That matters because the re-rating can start well before the listing itself as buy-side models begin to price in lower discount rates and broader ownership eligibility.

The LTAs are the more important second-order catalyst: they reduce the amplitude of the memory cycle by shifting the business from spot-exposed volume to contracted mix. That should mechanically lower earnings volatility, which can be more impactful to valuation than top-line growth because it supports a higher terminal multiple and easier debt refinancing. The knock-on winner is any supplier or customer that benefits from Kioxia committing capacity earlier, while the biggest loser is the purely cyclical bear case that relies on peak-downturn mean reversion.

The main risk is timing. A FY27 listing is far enough away that the trade can stall if memory pricing softens first or if execution slips on underwriting, governance, or free float structure. If the market starts to treat the LTAs as a cap on upside rather than a floor under downside, the re-rating could remain muted even with better visibility.

Consensus seems to be viewing this as a slow-burn quality story, but the hidden edge is that the equity could re-rate on narrative before fundamentals fully inflect. The setup is asymmetric because the downside is mostly delay risk, while the upside is multiple expansion plus reduced earnings dispersion. For SNDK, that means the peer multiple may stay elevated near term, but any successful Kioxia listing narrows the gap and can force relative-value rotations in memory equity baskets.

Key Decisions for Investors

• Long Kioxia on pullbacks, 6-12 month horizon: position for pre-listing re-rating; thesis is multiple compression vs SNDK rather than immediate earnings acceleration. Use a staged entry and add on confirmation of listing milestones.
• Pair trade: long Kioxia / short SNDK when the U.S. listing process becomes more concrete, targeting valuation-gap convergence over 6-18 months. Risk is that SNDK remains the cleaner U.S.-listed liquidity vehicle and outperforms on sentiment.
• Buy medium-dated call spreads on Kioxia into catalyst windows around listing updates, seeking leveraged exposure to a narrow multiple expansion scenario with defined downside. Best if implied vol remains below the event risk being priced.
• For relative value, monitor memory suppliers and equipment names for second-order benefit from stronger contracting discipline; overweight the names most exposed to reduced spot-price volatility and underweight highly levered cyclical analogs.
• If Kioxia fails to hit FY27 listing milestones or LTAs get renegotiated lower, exit quickly: the long case is catalyst-dependent and loses much of its valuation support if execution slips.